SUTRO BIOPHARMA, INC. (STRO) Net income 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$191.1MFY2025 · since FY2016: $1.7M → -$191.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$191.1M | +16.0% |
| FY2024 | -$227.5M | -113.0% |
| FY2023 | -$106.8M | +10.4% |
| FY2022 | -$119.2M | -12.9% |
| FY2021 | -$105.5M | -228.5% |
| FY2020 | -$32.1M | +73.0% |
| FY2019 | -$119.2M | -237.5% |
| FY2018 | -$35.3M | -79.4% |
| FY2017 | -$19.7M | -1256.8% |
| FY2016 | $1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STRO financial trends
STRO RevenueSTRO Net marginSTRO Gross profitSTRO Gross marginSTRO Operating incomeSTRO Operating marginSTRO Operating cash flowSTRO Free cash flowSTRO Capital expendituresSTRO Return on equitySTRO Stock buybacksSTRO Dividends paidSTRO Total assetsSTRO Total liabilitiesSTRO Shareholders’ equitySTRO overview →